A change in leadership would mark a proper show of accountability for the firm’s role in the opioid crisis, plus a chance to reset its culture.
Read More at:
https://www.bloomberg.com/opinion/articles/2021-02-24/mckinsey-is-an-mba-case-study-in-crisis-as-kevin-sneader-looks-set-to-exit